Literature DB >> 12416274

Drug class effects: definitions and practical applications.

Isabel Soares1, António Vaz Carneiro.   

Abstract

The concept of drug class effect is profoundly rooted in clinical practice. The use of drugs seen as similar in their clinical effects--and therefore interchangeable--is very frequent: two examples of this are the use of beta-blockers in arterial hypertension and angiotensin-converting enzyme (ACE) inhibitors in congestive heart failure. The definition of drug class effect is based on three concepts: a similar chemical structure (for example, the dihydropyridine ring of some calcium channel blockers), a similar mechanism of action (beta-blockers block adrenoreceptors), or similar pharmacological effects (antihypertensives, antianginals, etc.). In this article, we will describe the type of evidence that a cardiologist can use in order to select a specific drug (from within a class). It constitutes a clinical approach, different from the one that might be used by a third party payer (more interested in cost-effectiveness issues) or the pharmaceutical industry (more interested in promoting sales). As usual, the recommendations are based on the strength of scientific evidence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416274

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  3 in total

1.  Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.

Authors:  Liwei Wang; Mei Li; Jiangan Xie; Yuying Cao; Hongfang Liu; Yongqun He
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

Review 2.  SGLT2 Inhibitors and Cardiovascular Outcomes: Do they Differ or there is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study.

Authors:  Georgios Kyriakos; Lourdes V Quiles-Sanchez; Anna Garmpi; Paraskevi Farmaki; Konstantina Kyre; Spyridon Savvanis; Vasileios K Antoniou; Eleni Memi
Journal:  Curr Cardiol Rev       Date:  2020

3.  uCARE Chem Suite and uCAREChemSuiteCLI: Tools for bacterial resistome prediction.

Authors:  Saurav Bhaskar Saha; Vijai Kumar Gupta; Pramod Wasudeo Ramteke
Journal:  Genes Dis       Date:  2020-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.